Related Experiment Video
Updated: Aug 13, 2026

Murine Left Anterior Descending (LAD) Coronary Artery Ligation: An Improved and Simplified Model for Myocardial Infarction
Published on: April 2, 2017
Insights
Long-term anticoagulation may be beneficial for patients with left ventricular aneurysm and mural thrombus. Early detection of high-risk myocardial infarction patients is crucial for preventing complications like left ventricular aneurysm and mural thrombus.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Thrombosis Research
Background:
- Mural thrombus formation is a known complication of myocardial infarction and cardiomyopathy.
- Left ventricular aneurysm can develop following large, transmural myocardial infarctions.
- Anticoagulation is a potential therapeutic strategy but carries inherent risks.
Purpose of the Study:
- To review the indications for anticoagulation in patients with left ventricular aneurysm and mural thrombus.
- To identify patient groups at high risk for developing left ventricular aneurysm and mural thrombus after myocardial infarction.
- To discuss the risks and benefits of anticoagulation in these patient populations.
Main Methods:
- Review of existing literature and clinical guidelines.
- Analysis of patient data regarding mural thrombus development and anticoagulation outcomes.
- Risk-benefit assessment of anticoagulant therapy in specific clinical scenarios.
Main Results:
- Mural thrombus in left ventricular aneurysm warrants consideration of long-term anticoagulation.
- Serial noninvasive imaging is recommended for high-risk myocardial infarction patients to detect aneurysm/thrombus.
- Anticoagulants are advised for mural thrombi complicating infarction and in congestive cardiomyopathy.
Conclusions:
- Anticoagulation is a key consideration for mural thrombus in left ventricular aneurysm and congestive cardiomyopathy.
- Risk stratification and individualized assessment are essential before initiating anticoagulant therapy.
- Balancing the benefits of anticoagulation against bleeding risks is critical for patient management.
Abstract:
The identification of mural thrombus in patients with left ventricular aneurysm and mural thrombus probably warrants consideration of long-term anticoagulation. In patients with acute, large, anterior or anteroapical, transmural myocardial infarctions, serial noninvasive examinations are warranted to define a group of patients at high risk for the development of left ventricular aneurysm and/or mural thrombus. Anticoagulants should be considered in patients in whom mural thrombi develop as a complication of their infarction. Patients with congestive cardiomyopathy should be considered for long-term anticoagulation. These recommendations are all tempered by the realization that the use of anticoagulant therapy is not without its own risks. The decision to anticoagulate must be balanced against each individual patient's suitability for such therapy and the individual likelihood of the development of side effects.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Venous Thrombosis I: Introduction

